CLS Investments »

Dyne Therapeutics shares owned by CLS Investments

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by CLS Investments from 13F filings

Historical chart of CLS Investments investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by CLS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by CLS Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $490k 27k 18.13

More positions owned by CLS Investments

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Advisors Inner Circle Fd Ii 3edge Dynamic Fi (EDGF)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Ishares Tr Core S&p500 Etf (IVV)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation Call Option (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Msci Total (IXUS)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Us Aggbd Et (AGG)
Amazon (AMZN)

View all positions for CLS Investments

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Henderson Group
BlackRock
Vanguard Group
Atlas Venture Life Science Advisors
Orbis Allan Gray
State Street Corporation
FMR
Vanguard Capital Management
Fcpm Iii Services B.v.
Adage Capital Partners GP
Perceptive Advisors
TCG Crossover Management
Vanguard Portfolio Management
Vestal Point Capital

View all funds holding Dyne Therapeutics